nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiloride—ASIC2—peripheral nervous system—Parkinson's disease	0.0534	0.129	CbGeAlD
Amiloride—ASIC2—nerve—Parkinson's disease	0.0416	0.101	CbGeAlD
Amiloride—ASIC2—forebrain—Parkinson's disease	0.0172	0.0417	CbGeAlD
Amiloride—ASIC2—medulla oblongata—Parkinson's disease	0.0125	0.0301	CbGeAlD
Amiloride—AOC1—embryo—Parkinson's disease	0.0123	0.0298	CbGeAlD
Amiloride—SLC9A1—embryo—Parkinson's disease	0.0118	0.0285	CbGeAlD
Amiloride—SCNN1D—forebrain—Parkinson's disease	0.0111	0.0268	CbGeAlD
Amiloride—ASIC1—forebrain—Parkinson's disease	0.0109	0.0263	CbGeAlD
Amiloride—ASIC2—head—Parkinson's disease	0.00988	0.0239	CbGeAlD
Amiloride—ASIC2—nervous system—Parkinson's disease	0.00936	0.0226	CbGeAlD
Amiloride—ASIC2—central nervous system—Parkinson's disease	0.00902	0.0218	CbGeAlD
Amiloride—SLC9A1—cardiovascular system—Parkinson's disease	0.00884	0.0213	CbGeAlD
Amiloride—ASIC2—cerebellum—Parkinson's disease	0.00881	0.0213	CbGeAlD
Amiloride—PLAU—cardiovascular system—Parkinson's disease	0.00838	0.0202	CbGeAlD
Amiloride—ASIC1—medulla oblongata—Parkinson's disease	0.00788	0.019	CbGeAlD
Amiloride—ASIC1—midbrain—Parkinson's disease	0.0072	0.0174	CbGeAlD
Amiloride—ASIC2—brain—Parkinson's disease	0.00716	0.0173	CbGeAlD
Amiloride—ASIC1—spinal cord—Parkinson's disease	0.00703	0.017	CbGeAlD
Amiloride—SLC9A1—midbrain—Parkinson's disease	0.0069	0.0167	CbGeAlD
Amiloride—SCNN1D—head—Parkinson's disease	0.00636	0.0154	CbGeAlD
Amiloride—ASIC1—head—Parkinson's disease	0.00625	0.0151	CbGeAlD
Amiloride—SCNN1D—nervous system—Parkinson's disease	0.00603	0.0146	CbGeAlD
Amiloride—SLC9A1—head—Parkinson's disease	0.00598	0.0145	CbGeAlD
Amiloride—ASIC1—nervous system—Parkinson's disease	0.00592	0.0143	CbGeAlD
Amiloride—SCNN1D—central nervous system—Parkinson's disease	0.00581	0.014	CbGeAlD
Amiloride—ASIC1—central nervous system—Parkinson's disease	0.0057	0.0138	CbGeAlD
Amiloride—SCNN1G—cerebellum—Parkinson's disease	0.00568	0.0137	CbGeAlD
Amiloride—SCNN1D—cerebellum—Parkinson's disease	0.00568	0.0137	CbGeAlD
Amiloride—SLC9A1—nervous system—Parkinson's disease	0.00567	0.0137	CbGeAlD
Amiloride—PLAU—head—Parkinson's disease	0.00567	0.0137	CbGeAlD
Amiloride—ASIC1—cerebellum—Parkinson's disease	0.00557	0.0135	CbGeAlD
Amiloride—SLC9A1—central nervous system—Parkinson's disease	0.00546	0.0132	CbGeAlD
Amiloride—PLAU—nervous system—Parkinson's disease	0.00538	0.013	CbGeAlD
Amiloride—SCNN1B—head—Parkinson's disease	0.00538	0.013	CbGeAlD
Amiloride—SLC9A1—cerebellum—Parkinson's disease	0.00534	0.0129	CbGeAlD
Amiloride—PLAU—central nervous system—Parkinson's disease	0.00518	0.0125	CbGeAlD
Amiloride—SCNN1B—nervous system—Parkinson's disease	0.0051	0.0123	CbGeAlD
Amiloride—SCNN1A—head—Parkinson's disease	0.00497	0.012	CbGeAlD
Amiloride—SCNN1B—central nervous system—Parkinson's disease	0.00491	0.0119	CbGeAlD
Amiloride—SCNN1D—brain—Parkinson's disease	0.00461	0.0111	CbGeAlD
Amiloride—ASIC1—brain—Parkinson's disease	0.00453	0.0109	CbGeAlD
Amiloride—SLC9A1—brain—Parkinson's disease	0.00434	0.0105	CbGeAlD
Amiloride—PLAU—brain—Parkinson's disease	0.00411	0.00993	CbGeAlD
Amiloride—SCNN1B—brain—Parkinson's disease	0.0039	0.00941	CbGeAlD
Amiloride—SCNN1A—brain—Parkinson's disease	0.0036	0.0087	CbGeAlD
Amiloride—SLC22A1—forebrain—Parkinson's disease	0.00331	0.00799	CbGeAlD
Amiloride—SLC22A4—spinal cord—Parkinson's disease	0.00224	0.00541	CbGeAlD
Amiloride—SLC22A1—head—Parkinson's disease	0.0019	0.00458	CbGeAlD
Amiloride—SLC22A1—nervous system—Parkinson's disease	0.0018	0.00434	CbGeAlD
Amiloride—SLC22A4—cerebellum—Parkinson's disease	0.00178	0.00429	CbGeAlD
Amiloride—SLC22A1—central nervous system—Parkinson's disease	0.00173	0.00418	CbGeAlD
Amiloride—SLC22A4—brain—Parkinson's disease	0.00144	0.00348	CbGeAlD
Amiloride—SLC22A1—brain—Parkinson's disease	0.00137	0.00332	CbGeAlD
Amiloride—PLAU—ATF-2 transcription factor network—MAPK8—Parkinson's disease	0.00132	0.00226	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—CP—Parkinson's disease	0.00129	0.00221	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—CP—Parkinson's disease	0.00129	0.00221	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—CP—Parkinson's disease	0.00129	0.00221	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—CP—Parkinson's disease	0.00129	0.00221	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—CP—Parkinson's disease	0.00129	0.00221	CbGpPWpGaD
Amiloride—SLC22A2—Neurotransmitter Release Cycle—HSPA8—Parkinson's disease	0.00123	0.0021	CbGpPWpGaD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—Parkinson's disease	0.00123	0.00209	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—INS—Parkinson's disease	0.00122	0.00208	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.00122	0.00208	CbGpPWpGaD
Amiloride—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Parkinson's disease	0.0012	0.00206	CbGpPWpGaD
Amiloride—SLC9A1—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.0012	0.00204	CbGpPWpGaD
Amiloride—SLC9A1—Disease—VPS35—Parkinson's disease	0.00118	0.00201	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—MAG—Parkinson's disease	0.00117	0.002	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.00117	0.00199	CbGpPWpGaD
Amiloride—SLC22A1—Neurotransmitter Release Cycle—HSPA8—Parkinson's disease	0.00115	0.00196	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MCCC1—Parkinson's disease	0.0011	0.00187	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—HCN3—Parkinson's disease	0.00104	0.00178	CbGpPWpGaD
Amiloride—SLC9A1—Disease—TALDO1—Parkinson's disease	0.00103	0.00176	CbGpPWpGaD
Amiloride—SLC9A1—Disease—OMD—Parkinson's disease	0.00103	0.00176	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.00102	0.00173	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000975	0.00166	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—HCN3—Parkinson's disease	0.000971	0.00166	CbGpPWpGaD
Amiloride—SLC22A2—Neurotransmitter Release Cycle—MAOA—Parkinson's disease	0.00094	0.0016	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000927	0.00158	CbGpPWpGaD
Amiloride—SLC9A1—ErbB1 downstream signaling—MAPK8—Parkinson's disease	0.000924	0.00158	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000922	0.00157	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000922	0.00157	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000922	0.00157	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000922	0.00157	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000922	0.00157	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—MCCC1—Parkinson's disease	0.000918	0.00157	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ND3—Parkinson's disease	0.000918	0.00157	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—IL1B—Parkinson's disease	0.000909	0.00155	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000885	0.00151	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000885	0.00151	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000885	0.00151	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000885	0.00151	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000885	0.00151	CbGpPWpGaD
Amiloride—SLC22A1—Neurotransmitter Release Cycle—MAOA—Parkinson's disease	0.000876	0.0015	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—KCNJ4—Parkinson's disease	0.000876	0.00149	CbGpPWpGaD
Amiloride—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC18A2—Parkinson's disease	0.000869	0.00148	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—OMD—Parkinson's disease	0.000863	0.00147	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—TALDO1—Parkinson's disease	0.000863	0.00147	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000853	0.00146	CbGpPWpGaD
Amiloride—PLAU—ATF-2 transcription factor network—IL6—Parkinson's disease	0.000844	0.00144	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.000835	0.00143	CbGpPWpGaD
Amiloride—SLC9A1—Disease—FBP1—Parkinson's disease	0.000831	0.00142	CbGpPWpGaD
Amiloride—SLC9A1—Disease—TAF1—Parkinson's disease	0.000831	0.00142	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—NDUFB11—Parkinson's disease	0.000818	0.0014	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—KCNJ4—Parkinson's disease	0.000816	0.00139	CbGpPWpGaD
Amiloride—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC18A2—Parkinson's disease	0.00081	0.00138	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—MAPK8—Parkinson's disease	0.000809	0.00138	CbGpPWpGaD
Amiloride—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—Parkinson's disease	0.0008	0.00137	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.0008	0.00136	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.0008	0.00136	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GCH1—Parkinson's disease	0.000781	0.00133	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.00077	0.00131	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.00077	0.00131	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.00077	0.00131	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.00077	0.00131	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.00077	0.00131	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.000768	0.00131	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—DLG1—Parkinson's disease	0.000756	0.00129	CbGpPWpGaD
Amiloride—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—Parkinson's disease	0.000745	0.00127	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—FGB—Parkinson's disease	0.00074	0.00126	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000739	0.00126	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000739	0.00126	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000739	0.00126	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000739	0.00126	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000739	0.00126	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—IL6—Parkinson's disease	0.000736	0.00126	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—DLG1—Parkinson's disease	0.000705	0.0012	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—FBP1—Parkinson's disease	0.000696	0.00119	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GBA—Parkinson's disease	0.000696	0.00119	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—DBH—Parkinson's disease	0.000696	0.00119	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—KCNJ4—Parkinson's disease	0.000671	0.00115	CbGpPWpGaD
Amiloride—SLC9A1—Disease—RPL6—Parkinson's disease	0.000664	0.00113	CbGpPWpGaD
Amiloride—SLC9A1—Disease—SNCA—Parkinson's disease	0.000664	0.00113	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—KCNJ4—Parkinson's disease	0.000625	0.00107	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000608	0.00104	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—GRIK1—Parkinson's disease	0.000592	0.00101	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000584	0.000996	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—DLG1—Parkinson's disease	0.000579	0.000989	CbGpPWpGaD
Amiloride—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Parkinson's disease	0.00057	0.000973	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—GRIK1—Parkinson's disease	0.000551	0.000941	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—SOD1—Parkinson's disease	0.000549	0.000937	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.000548	0.000934	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—DLG1—Parkinson's disease	0.00054	0.000921	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—IL6—Parkinson's disease	0.000532	0.000909	CbGpPWpGaD
Amiloride—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Parkinson's disease	0.000531	0.000907	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—ABL1—Parkinson's disease	0.000524	0.000894	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—IGF2—Parkinson's disease	0.000522	0.00089	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—DDC—Parkinson's disease	0.000511	0.000872	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000507	0.000866	CbGpPWpGaD
Amiloride—SLC9A1—Disease—RPL23A—Parkinson's disease	0.000503	0.000859	CbGpPWpGaD
Amiloride—SLC9A1—Disease—RPL14—Parkinson's disease	0.000503	0.000859	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.000503	0.000858	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—HGF—Parkinson's disease	0.000493	0.000841	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.000487	0.000831	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000487	0.000831	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GSTA4—Parkinson's disease	0.000482	0.000823	CbGpPWpGaD
Amiloride—SLC9A1—Disease—RPS8—Parkinson's disease	0.000469	0.000801	CbGpPWpGaD
Amiloride—SLC9A1—Disease—FGF20—Parkinson's disease	0.000469	0.000801	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.000469	0.0008	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.000454	0.000775	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—GRIK1—Parkinson's disease	0.000453	0.000774	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PLA2G6—Parkinson's disease	0.000434	0.000741	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—MAOB—Parkinson's disease	0.00043	0.000734	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000424	0.000724	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—GRIK1—Parkinson's disease	0.000422	0.000721	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.000395	0.000674	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—CP—Parkinson's disease	0.00039	0.000666	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.000386	0.000658	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—GRIK2—Parkinson's disease	0.000385	0.000658	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000378	0.000645	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000378	0.000645	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—SLC18A2—Parkinson's disease	0.000373	0.000637	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.000368	0.000628	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.000363	0.00062	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.000359	0.000613	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—GRIK2—Parkinson's disease	0.000359	0.000613	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000353	0.000603	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000352	0.000602	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000352	0.000602	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—SLC18A2—Parkinson's disease	0.000348	0.000594	CbGpPWpGaD
Amiloride—SLC9A1—Disease—ADRBK1—Parkinson's disease	0.000345	0.000589	CbGpPWpGaD
Amiloride—SLC9A1—Disease—HSPA1A—Parkinson's disease	0.000342	0.000585	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.000339	0.000578	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000332	0.000566	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000329	0.000562	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000324	0.000553	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CYP2D6—Parkinson's disease	0.000319	0.000545	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000319	0.000545	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CTGF—Parkinson's disease	0.000314	0.000535	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000309	0.000528	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000302	0.000516	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000298	0.000508	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—CHRNA4—Parkinson's disease	0.000295	0.000504	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CYP2E1—Parkinson's disease	0.000292	0.000499	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—NQO1—Parkinson's disease	0.000289	0.000493	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—TH—Parkinson's disease	0.000285	0.000486	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000278	0.000475	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—CHRNA4—Parkinson's disease	0.000275	0.00047	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CYCS—Parkinson's disease	0.000273	0.000467	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000272	0.000464	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—HSPA8—Parkinson's disease	0.000271	0.000462	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.00027	0.00046	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000267	0.000456	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.000259	0.000442	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—DLG4—Parkinson's disease	0.000254	0.000434	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000253	0.000432	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—HSPA8—Parkinson's disease	0.000252	0.000431	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000251	0.000429	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—GRIN2B—Parkinson's disease	0.000248	0.000424	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—SLC6A3—Parkinson's disease	0.000245	0.000418	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—COMT—Parkinson's disease	0.000242	0.000413	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.000241	0.000412	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GSTP1—Parkinson's disease	0.000241	0.000411	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—MAOA—Parkinson's disease	0.00024	0.00041	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—HMOX1—Parkinson's disease	0.000238	0.000406	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—DLG4—Parkinson's disease	0.000237	0.000404	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MTHFR—Parkinson's disease	0.000234	0.000399	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000232	0.000396	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—GRIN2B—Parkinson's disease	0.000231	0.000395	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—SLC6A3—Parkinson's disease	0.000228	0.000389	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ABCB1—Parkinson's disease	0.000228	0.000389	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000223	0.00038	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GSTM1—Parkinson's disease	0.000221	0.000378	CbGpPWpGaD
Amiloride—SLC9A1—Disease—APOE—Parkinson's disease	0.000218	0.000371	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GPX1—Parkinson's disease	0.000212	0.000362	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—COMT—Parkinson's disease	0.000208	0.000355	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—MAOA—Parkinson's disease	0.000207	0.000353	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000201	0.000343	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—MCCC1—Parkinson's disease	0.000199	0.000339	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ND3—Parkinson's disease	0.000199	0.000339	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—MTHFR—Parkinson's disease	0.000196	0.000334	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—COMT—Parkinson's disease	0.000194	0.000331	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—MAOA—Parkinson's disease	0.000193	0.000329	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000187	0.000319	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—TALDO1—Parkinson's disease	0.000187	0.000319	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—OMD—Parkinson's disease	0.000187	0.000319	CbGpPWpGaD
Amiloride—SLC9A1—Disease—INS—Parkinson's disease	0.000186	0.000317	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ND3—Parkinson's disease	0.000185	0.000316	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—MCCC1—Parkinson's disease	0.000185	0.000316	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000185	0.000315	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—APOE—Parkinson's disease	0.000182	0.000311	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NDUFB11—Parkinson's disease	0.000177	0.000302	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—TALDO1—Parkinson's disease	0.000174	0.000297	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—OMD—Parkinson's disease	0.000174	0.000297	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000172	0.000294	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GCH1—Parkinson's disease	0.000169	0.000288	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NDUFB11—Parkinson's disease	0.000165	0.000282	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GCH1—Parkinson's disease	0.000157	0.000269	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—INS—Parkinson's disease	0.000156	0.000266	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GBA—Parkinson's disease	0.000151	0.000257	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—FBP1—Parkinson's disease	0.000151	0.000257	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—DBH—Parkinson's disease	0.000151	0.000257	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GBA—Parkinson's disease	0.00014	0.00024	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—DBH—Parkinson's disease	0.00014	0.00024	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—FBP1—Parkinson's disease	0.00014	0.00024	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000132	0.000225	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000126	0.000216	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000123	0.000209	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000118	0.000201	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—DDC—Parkinson's disease	0.000111	0.000189	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.00011	0.000187	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000105	0.00018	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTA4—Parkinson's disease	0.000104	0.000178	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—DDC—Parkinson's disease	0.000103	0.000176	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000102	0.000175	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	9.83e-05	0.000168	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTA4—Parkinson's disease	9.73e-05	0.000166	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PLA2G6—Parkinson's disease	9.4e-05	0.00016	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—MAOB—Parkinson's disease	9.3e-05	0.000159	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PLA2G6—Parkinson's disease	8.76e-05	0.00015	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—MAOB—Parkinson's disease	8.67e-05	0.000148	CbGpPWpGaD
Amiloride—SLC9A1—Disease—IL6—Parkinson's disease	8.12e-05	0.000139	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP2D6—Parkinson's disease	6.92e-05	0.000118	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CTGF—Parkinson's disease	6.79e-05	0.000116	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP2D6—Parkinson's disease	6.45e-05	0.00011	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CTGF—Parkinson's disease	6.33e-05	0.000108	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP2E1—Parkinson's disease	6.32e-05	0.000108	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NQO1—Parkinson's disease	6.25e-05	0.000107	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—TH—Parkinson's disease	6.16e-05	0.000105	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYCS—Parkinson's disease	5.92e-05	0.000101	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP2E1—Parkinson's disease	5.89e-05	0.000101	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NQO1—Parkinson's disease	5.83e-05	9.95e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—TH—Parkinson's disease	5.74e-05	9.8e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYCS—Parkinson's disease	5.52e-05	9.41e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—COMT—Parkinson's disease	5.24e-05	8.94e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTP1—Parkinson's disease	5.22e-05	8.9e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—MAOA—Parkinson's disease	5.2e-05	8.88e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HMOX1—Parkinson's disease	5.14e-05	8.78e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ABCB1—Parkinson's disease	4.94e-05	8.43e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—COMT—Parkinson's disease	4.88e-05	8.34e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTP1—Parkinson's disease	4.86e-05	8.3e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—MAOA—Parkinson's disease	4.85e-05	8.28e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HMOX1—Parkinson's disease	4.79e-05	8.18e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTM1—Parkinson's disease	4.79e-05	8.18e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ABCB1—Parkinson's disease	4.6e-05	7.85e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GPX1—Parkinson's disease	4.59e-05	7.83e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTM1—Parkinson's disease	4.47e-05	7.62e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GPX1—Parkinson's disease	4.28e-05	7.3e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—MTHFR—Parkinson's disease	4.24e-05	7.23e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—MTHFR—Parkinson's disease	3.95e-05	6.74e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—APOE—Parkinson's disease	3.94e-05	6.73e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—APOE—Parkinson's disease	3.68e-05	6.27e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—INS—Parkinson's disease	3.37e-05	5.75e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—INS—Parkinson's disease	3.14e-05	5.36e-05	CbGpPWpGaD
